Advanced search
Publication Cover
Acta Oncologica Volume 61, 2022 - Issue 4
Journal homepage
2,862
Views
4
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLES: CLINICAL ONCOLOGY

Clinical features affecting efficacy of immune checkpoint inhibitors in pretreated patients with advanced NSCLC: a Danish nationwide real-world study

Mette T. Mouritzena Department of Oncology, Aalborg University Hospital, Aalborg, Denmark;b Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark;c Department of Clinical Medicine, Aalborg University, Aalborg, DenmarkCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-2061-3536View further author information
ORCID Icon,
Karen F. Junkerd Department of Oncology, Copenhagen E, DenmarkView further author information
,
Andreas Carusa Department of Oncology, Aalborg University Hospital, Aalborg, Denmark;b Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark;c Department of Clinical Medicine, Aalborg University, Aalborg, DenmarkORCID Iconhttps://orcid.org/0000-0001-9369-8628View further author information
ORCID Icon,
Morten Ladekarla Department of Oncology, Aalborg University Hospital, Aalborg, Denmark;b Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark;c Department of Clinical Medicine, Aalborg University, Aalborg, DenmarkORCID Iconhttps://orcid.org/0000-0002-0182-1228View further author information
ORCID Icon,
Peter Meldgaarde Department of Oncology, Aarhus University Hospital, Aarhus N, DenmarkView further author information
,
Anders W. M. Nielsene Department of Oncology, Aarhus University Hospital, Aarhus N, DenmarkORCID Iconhttps://orcid.org/0000-0003-2843-2879View further author information
ORCID Icon,
Anna Livbjerge Department of Oncology, Aarhus University Hospital, Aarhus N, DenmarkView further author information
,
Jacob W. Larsenf Department of Oncology, Region Hospital West Jutland, Herning, DenmarkORCID Iconhttps://orcid.org/0000-0002-0844-7881View further author information
ORCID Icon,
Halla Skuladottirf Department of Oncology, Region Hospital West Jutland, Herning, DenmarkView further author information
,
Charlotte Kristianseng Department of Oncology, Vejle Hospital, University Hospital of Southern Denmark, Vejle, DenmarkORCID Iconhttps://orcid.org/0000-0002-8073-5781View further author information
ORCID Icon,
Kim Wedervangh Department of Oncology, Hospital Sønderjylland, Sønderborg, DenmarkView further author information
,
Tine Schyttei Department of Oncology, Odense University Hospital, Odense, Denmark;j Department of Clinical Research, University of Southern Denmark, Odense, Denmark;k Odense Patient data Explorative Network (OPEN), Odense, DenmarkView further author information
,
Karin H. Hanseni Department of Oncology, Odense University Hospital, Odense, Denmark;j Department of Clinical Research, University of Southern Denmark, Odense, Denmark;k Odense Patient data Explorative Network (OPEN), Odense, DenmarkView further author information
,
Anne-Cathrine Østbyl Department of Clinical Oncology and Palliative Care, Zealand University Hospital, Roskilde, DenmarkView further author information
,
Malene S. Frankl Department of Clinical Oncology and Palliative Care, Zealand University Hospital, Roskilde, Denmark;m Department of Clinical Medicine, University of Copenhagen, Copenhagen N, DenmarkView further author information
,
Jakob Lauritsenl Department of Clinical Oncology and Palliative Care, Zealand University Hospital, Roskilde, DenmarkView further author information
,
Jens B. Sørensend Department of Oncology, Copenhagen E, Denmark;m Department of Clinical Medicine, University of Copenhagen, Copenhagen N, DenmarkORCID Iconhttps://orcid.org/0000-0001-7780-0178View further author information
ORCID Icon,
Seppo W. Langerd Department of Oncology, Copenhagen E, Denmark;m Department of Clinical Medicine, University of Copenhagen, Copenhagen N, DenmarkORCID Iconhttps://orcid.org/0000-0001-9732-9192View further author information
ORCID Icon,
Gitte F. Perssonm Department of Clinical Medicine, University of Copenhagen, Copenhagen N, Denmark;n Department of Oncology, Copenhagen University Hospital, Herlev, DenmarkView further author information
,
Jon L. Andersenn Department of Oncology, Copenhagen University Hospital, Herlev, DenmarkView further author information
,
Pernille H. Homanno Department of Oncology, North Zealand Hospital, Hillerød, DenmarkView further author information
,
Emilie B. Kristenseno Department of Oncology, North Zealand Hospital, Hillerød, DenmarkView further author information
,
Lars B. Drivsholmo Department of Oncology, North Zealand Hospital, Hillerød, DenmarkView further author information
,
Martin Bøgstedp Department of Hematology, Aalborg University Hospital, Aalborg, Denmark;b Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark;c Department of Clinical Medicine, Aalborg University, Aalborg, DenmarkORCID Iconhttps://orcid.org/0000-0001-9192-1814View further author information
ORCID Icon,
Heidi S. Christensenp Department of Hematology, Aalborg University Hospital, Aalborg, Denmark;b Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark;c Department of Clinical Medicine, Aalborg University, Aalborg, DenmarkView further author information
,
Mette Pøhld Department of Oncology, Copenhagen E, DenmarkView further author information
&
Birgitte Bjørnharti Department of Oncology, Odense University Hospital, Odense, Denmark;j Department of Clinical Research, University of Southern Denmark, Odense, Denmark;k Odense Patient data Explorative Network (OPEN), Odense, DenmarkORCID Iconhttps://orcid.org/0000-0002-1331-061XView further author information
ORCID Icon show all
Pages 409-416 | Received 30 Sep 2021, Accepted 17 Dec 2021, Published online: 11 Jan 2022

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Birgitte Bjørnhart, Mette Thune Mouritzen, Charlotte Kristiansen, Tine Schytte, Kim Wedervang, Mette Pøhl & Karin Holmskov Hansen. (2023) 5-Year survival in Danish patients with advanced non-small cell lung cancer treated with immune checkpoint inhibitor monotherapy. Acta Oncologica 62:8, pages 861-870.
Read now
Fabian Gärtner, Jörg Aßmus, Øystein Fløtten, Maria Paula Ramnefjell & Marianne Aanerud. (2022) Characteristics and survival of patients with non-small cell lung cancer treated with immune-checkpoint inhibitors in the real-world: experiences from Bergen, Norway. Acta Oncologica 61:7, pages 814-818.
Read now

Articles from other publishers (2)

Magdalena Knetki-Wróblewska, Sylwia Tabor, Aleksandra Piórek, Adam Płużański, Kinga Winiarczyk, Magdalena Zaborowska-Szmit, Katarzyna Zajda, Dariusz M. Kowalski & Maciej Krzakowski. (2023) Nivolumab or Atezolizumab in the Second-Line Treatment of Advanced Non-Small Cell Lung Cancer? A Prognostic Index Based on Data from Daily Practice. Journal of Clinical Medicine 12:6, pages 2409.
Crossref
Birgitte Bjørnhart, Karin Holmskov Hansen, Jon Thor Asmussen, Trine Lembrecht Jørgensen, Jørn Herrstedt & Tine Schytte. (2022) Effect and Tolerability of Immunotherapy in Patients with NSCLC with or without Brain Metastasis. Cancers 14:7, pages 1682.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.